OUTPATIENT FOLLOW-UP OF THE LOWER EXTREMITIES ATHEROSCLEROSIS PATIENTS FROM CARDIOLOGIST POINT OF VIEW
https://doi.org/10.15829/1560-4071-2016-12-9-15
Abstract
Aim. To study clinical characteristics of patients with lower extremities atherosclerosis form cardiologist point of view.
Material and methods. Totally, 458 patients included (372 (79%) males and 84 (18,4%) females, median age 63 year-old, from 45 to 81) with obliterating atherosclerosis of lower extremities. Patients were examined by cardiologist under the framework of registry at Kemerovo Cardiovascular center, in 2009-2013. For the study, two groups were selected according to Russian classification of chronic lower extremities vessels ischemia (CLEI) stage by Fountain-Pokrovsky: Group 1 (n=196) with CLEI 1-2a stage, Group 2 (n=260) with CLEI 2b-4 stage.
Results. Among patients with obliterating lower extremities arteries diseases there was high prevalence of cardiocerebral pathology: myocardial infarction in anamnesis 34,4%, and clinical signs of angina in 48,5%, stroke anamnesis in 14,3% and extracranial stenosis of arteries in 12,3%. Also, the prescribed cardiovascular protective therapy was not optimal: statins were being taken by 64,5%, betablockers by 65,6%, ACE inhibitors by 52,4%. There was no difference in the prevalence of cardiovascular pathology and received treatment among groups with various severity of obliteration of arteries.
Conclusion. For an improvement of secondary prevention, it is aim worthy to apply in patients with obliteration diseases of lower extremities the new organizational approaches at outpatient stage.
About the Authors
A. N Sumin
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Doctor of Medical Sciences, Head of the Department of multifocal atherosclerosis
Competing Interests: no conflict of interest
Russian Federation
Doctor of Medical Sciences, Head of the Department of multifocal atherosclerosis
Competing Interests: no conflict of interest
M. A. Kosova
Kemerovo Cardiovasular Dispensary
Russian Federation
cardiologist
Competing Interests: no conflict of interest
Russian Federation
cardiologist
Competing Interests: no conflict of interest
Yu. D. Medvedevа
Kemerovo Cardiovasular Dispensary
Russian Federation
cardio-vascular surgeon
Competing Interests: no conflict of interest
Russian Federation
cardio-vascular surgeon
Competing Interests: no conflict of interest
A. V. Shcheglova
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Candidate of Medical Sciences, junior research laboratory of Circulation Pathology at the multifocal atherosclerosis Department
Competing Interests: no conflict of interest
Russian Federation
Candidate of Medical Sciences, junior research laboratory of Circulation Pathology at the multifocal atherosclerosis Department
Competing Interests: no conflict of interest
S. A. Makarov
Kemerovo Cardiovasular Dispensary
Russian Federation
Doctor of Medical Science, chief medical officer
Competing Interests: no conflict of interest
Russian Federation
Doctor of Medical Science, chief medical officer
Competing Interests: no conflict of interest
G. V. Artamonova
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Doctor of Medical Science, Professor, Deputy Director for Science
Competing Interests: no conflict of interest
Russian Federation
Doctor of Medical Science, Professor, Deputy Director for Science
Competing Interests: no conflict of interest
L. S. Barbarash
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Competing Interests: no conflict of interest
Russian Federation
Academician of RAS, Professor, Doctor of Medical Sciences,
Chief Scientific OfficerCompeting Interests: no conflict of interest
References
1. National guidelines for management of patients with lower extremity arterial disease. Moscow, 2013. р 74. Russian (Национальные рекомендации по ведению пациентов с заболеваниями артерий нижних конечностей. Москва, 2013. 74с.).
2. Gallino A, Aboyans V, Diehm C, et al. European Society of Cardiology Working Group on Peripheral Circulation. Non-coronary atherosclerosis. Eur Heart J. 2014; 35(17): 1112-9.
3. Kumbhani DJ, Steg PG, Cannon CP, et al. REACH Registry Investigators. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J. 2014; 35(41):2864-72. doi: 10.1093/eurheartj/ehu080.
4. Montminy ML, Gauvin V, Turcotte S, et al. Factors Influencing the Prescription of Cardiovascular Preventive Therapies in Patients with Peripheral Arterial Disease. PLoS One. 2016; 11(2): e0148069. doi: 10.1371/journal.pone.0148069.
5. Barbarash LS, Sumin AN, Evdokimov DO, et al. The role of coronary angiography in reducing cardiac events in vascular operations, intermediate and high risk. Angiology and Vascular Surgery. 2012; 18 (4): 33-41. Russian (Барбараш Л.С., Сумин А.Н, Евдокимов Д.О. и др. Роль коронароангиографии в снижении числа кардиальных осложнений при сосудистых операциях промежуточного и высокого риска. Ангиология и сосудистая хирургия. 2012; 18(4): 33-41).
6. Russian recommendations diagnosis and correction of lipid metabolism in the prevention and treatment of atherosclerosis. Atherosclerosis and dyslipidemia. 2012; 4: 2-52. Russian (Российские рекомендации диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Атеросклероз и дислипидемия. 2012; 4: 2-52).
7. Welten GM, Schouten O, Hoeks SE, et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol. 2008; 51(16): 1588-96. doi: 10.1016/j.jacc.2007.11.077.
8. Armstrong EJ, Chen DC, Westin GG, et al. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease. J Am Heart Assoc. 2014; 3(2): e000697. doi: 10.1161/JAHA.113.000697.
9. Cacoub PP, Abola MTB, Baumgartner I, et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis. 2009; 204(2): e86-92. doi: 10.1016/j.atherosclerosis.2008.10.023 PMID: 19054514.
10. Kundhal KK, Chin SL, Harrison L, et al. Patterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in Canada. Can J Cardiol. Elsevier; 2007; 23(5): 357-61.
11. Subherwal S, Patel MR, Kober L, et al. Missed Opportunities: Despite Improvement in Use of Cardioprotective Medications Among Patients With Lower-Extremity Peripheral Artery Disease, Underuse Remains. Circulation. 2012; 126(11): 1345-54. doi: 10.1161/ CIRCULATIONAHA.112.108787 PMID: 22874581.
12. European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. The Task Force on the Diagnosis and Treat. Eur Heart J. 2011; 32(22): 2851-906. doi: 10.1093/eurheartj/ehr211 PMID: 21873417.
13. Aherne T, McHugh S, Kheirelseid EA, et al. Comparing Supervised Exercise Therapy to Invasive Measures in the Management of Symptomatic Peripheral Arterial Disease. Surg Res Pract. 2015; 2015: 960402. doi: 10.1155/2015/960402.
14. Sumin AN, Barbarash ОL. Physical training in peripheral atherosclerosis: problems and solutions. Angiology and Vascular Surgery 2013; 19 (3): 161-170. Russian (Сумин А. Н., Барбараш О. Л. Физические тренировки при периферическом атеросклерозе: проблемы и пути решения. Ангиология и сосудистая хирургия 2013; 19(3): 161-70.
15. Ardati AK, Kaufman SR, Aronow HD, et al. The Quality and Impact of Risk Factor Control in Patients With Stable Claudication Presenting for Peripheral Vascular Interventions. Circ Cardiovasc Interv. 2012; 5(6): 850-5. doi: 10.1161/CIRCINTERVENTIONS.112.975862 PMID: 23233746.
16. Lonchakova IJ, Makarov SA, Artamonova GV, et al. Organizational aspects of the treatment of patients with obliterating atherosclerosis of the lower limbs at the outpatient stage. Angiology and Vascular Surgery. 2015; 3: 38-42. Russian (Лончакова И. Ю., Макаров С. А., Артамонова Г. В. и др. Организационные аспекты лечения больных с облитерирующим атеросклерозом сосудов нижних конечностей на амбулаторном этапе. Ангиология и сосудистая хирургия. 2015; 3: 38-42).
Supplementary files
|
1. Неозаглавлен | |
| Subject | ||
| Type | Исследовательские инструменты | |
Download
(13KB)
|
Indexing metadata ▾ | |
|
2. Неозаглавлен | |
| Subject | ||
| Type | Исследовательские инструменты | |
Download
(358KB)
|
Indexing metadata ▾ | |
|
|
3. Неозаглавлен | |
| Subject | ||
| Type | Исследовательские инструменты | |
Download
(13KB)
|
Indexing metadata ▾ | |
Review
For citations:
Sumin A.N., Kosova M.A., Medvedevа Yu.D., Shcheglova A.V., Makarov S.A., Artamonova G.V., Barbarash L.S. OUTPATIENT FOLLOW-UP OF THE LOWER EXTREMITIES ATHEROSCLEROSIS PATIENTS FROM CARDIOLOGIST POINT OF VIEW. Russian Journal of Cardiology. 2016;(12):58-63. (In Russ.) https://doi.org/10.15829/1560-4071-2016-12-9-15
Views:
17884
Email this article 